These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31953349)

  • 1. Current and novel mapping substances in gynecologic cancer care.
    Moukarzel LA; Feinberg J; Levy EJ; Leitao MM
    Int J Gynecol Cancer; 2020 Mar; 30(3):387-393. PubMed ID: 31953349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
    Darin MC; Gómez-Hidalgo NR; Westin SN; Soliman PT; Escobar PF; Frumovitz M; Ramirez PT
    J Minim Invasive Gynecol; 2016 Feb; 23(2):186-93. PubMed ID: 26518716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of sentinel lymph node mapping of the ovary: a systematic review.
    Dell'Orto F; Laven P; Delle Marchette M; Lambrechts S; Kruitwagen R; Buda A
    Int J Gynecol Cancer; 2019 Sep; 29(7):1209-1215. PubMed ID: 31474589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
    Kessous R; How J; Abitbol J; Puzhakkal S; Kogan L; Yasmeen A; Salvador S; Gotlieb WH; Lau S
    Int J Gynecol Cancer; 2019 Sep; 29(7):1121-1125. PubMed ID: 31320490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
    Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where Are We Going with Sentinel Lymph Node Mapping in Gynecologic Cancers?
    Reneé Franklin C; Tanner EJ
    Curr Oncol Rep; 2018 Nov; 20(12):96. PubMed ID: 30421035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
    Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
    J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
    Rossi EC; Tanner E
    J Minim Invasive Gynecol; 2021 Mar; 28(3):409-417. PubMed ID: 33359741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs.
    Kumar A; Wallace SA; Cliby WA; Glaser GE; Mariani A; Leitao MM; Frumovitz M; Langstraat CL
    J Minim Invasive Gynecol; 2019; 26(4):727-732. PubMed ID: 30138740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology.
    Wisner KPA; Ahmad S; Holloway RW
    Best Pract Res Clin Obstet Gynaecol; 2017 Nov; 45():83-93. PubMed ID: 28533155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.
    Pölcher M; Matz S; Braun M; Brambs C; Beer M; Hamann M
    J Surg Oncol; 2021 Mar; 123(4):1092-1098. PubMed ID: 33333589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical versus Utero-Ovarian Ligament Injection of the Tracer for the Pelvic Sentinel Lymph Node Mapping in Gynecologic Oncology: A Prospective Observational Study.
    Uccella S; Garzon S; Bosco M; Porcari I; Lanzo G; Laganà AS; Chiantera V; Cliby WA; Mariani A; Franchi M; Zorzato PC
    Gynecol Obstet Invest; 2022; 87(3-4):242-247. PubMed ID: 35584619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymphatic mapping for gynecologic malignancies.
    Hari AY; Tewari KS
    Curr Opin Obstet Gynecol; 2023 Feb; 35(1):43-53. PubMed ID: 36595648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node mapping and sentinel node detection in gynecological oncology].
    Pityński K; Basta A
    Ginekol Pol; 2002 Nov; 73(11):1159-64. PubMed ID: 12722417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methylene blue dye for sentinel lymph node mapping in early-stage gynecological cancers - An option for low resource settings.
    Singh N; Agrawal S
    J Cancer Res Ther; 2022; 18(4):1088-1092. PubMed ID: 36149165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.